Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
NCT ID: NCT00607971
Last Updated: 2008-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
939 participants
INTERVENTIONAL
2006-04-30
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
All subjects take two capsules (2x renzapride 2 mg) daily, from the day of enrolment until the scheduled visit at the end of Week 52
Renzapride
All subjects take two capsules (2x renzapride 2 mg) daily, from the day of enrolment until the scheduled visit at the end of Week 52
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Renzapride
All subjects take two capsules (2x renzapride 2 mg) daily, from the day of enrolment until the scheduled visit at the end of Week 52
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alizyme
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alizyme Therapeutics Ltd
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anthony Lembo, MD
Role: PRINCIPAL_INVESTIGATOR
Beth Israel Deaconess Medical Center, Boston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Huntsville, Alabama, United States
Research Site
Chandler, Arizona, United States
Research Site
Phoenix, Arizona, United States
Research Site
Sierra Vista, Arizona, United States
Research Site
Little Rock, Arkansas, United States
Research Site
North Little Rock, Arkansas, United States
Research Site
Anaheim, California, United States
Research Site
Beverly Hills, California, United States
Research Site
Burbank, California, United States
Research Site
Carmichael, California, United States
Research Site
Cerritos, California, United States
Research Site
Chula Vista, California, United States
Research Site
Cypress, California, United States
Research Site
Laguna Hills, California, United States
Research Site
Los Angeles, California, United States
Research Site
Orange, California, United States
Research Site
Orange, California, United States
Research Site
San Carlos, California, United States
Research Site
San Diego, California, United States
Research Site
San Diego, California, United States
Research Site
San Francisco, California, United States
Research Site
Colorado Springs, Colorado, United States
Research Site
Lakewood, Colorado, United States
Research Site
Littleton, Colorado, United States
Research Site
Bristol, Connecticut, United States
Research Site
Boynton Beach, Florida, United States
Research Site
Coral Gables, Florida, United States
Research Site
Gainesville, Florida, United States
Research Site
Hialeah, Florida, United States
Research Site
Inverness, Florida, United States
Research Site
Jacksonville, Florida, United States
Research Site
Jacksonville, Florida, United States
Research Site
Kissimmee, Florida, United States
Research Site
Miami, Florida, United States
Research Site
New Port Richey, Florida, United States
Research Site
Palm Harbor, Florida, United States
Research Site
Pembrook Pines, Florida, United States
Research Site
Pensacola, Florida, United States
Research Site
Plantation, Florida, United States
Research Site
Port Orange, Florida, United States
Research Site
Vero Beach, Florida, United States
Research Site
West Palm Beach, Florida, United States
Research Site
Marietta, Georgia, United States
Research Site
Newnan, Georgia, United States
Research Site
Rockford, Illinois, United States
Research Site
Indianapolis, Indiana, United States
Research Site
Des Moines, Iowa, United States
Research Site
Arkansas City, Kansas, United States
Research Site
Overland Park, Kansas, United States
Research Site
Topeka, Kansas, United States
Research Site
Wichita, Kansas, United States
Research Site
Wichita, Kansas, United States
Research Site
Shreveport, Louisiana, United States
Research Site
Annapolis, Maryland, United States
Research Site
Hagerstown, Maryland, United States
Research Site
Laurel, Maryland, United States
Research Site
Pasadena, Maryland, United States
Research Site
Severna Park, Maryland, United States
Research Site
Boston, Massachusetts, United States
Research Site
Boston, Massachusetts, United States
Research Site
Chesterfield, Michigan, United States
Research Site
Kalamazoo, Michigan, United States
Research Site
Lansing, Michigan, United States
Research Site
Troy, Michigan, United States
Research Site
Tupelo, Mississippi, United States
Research Site
Mexico, Missouri, United States
Research Site
Springfield, Missouri, United States
Research Site
Scottsbluff, Nebraska, United States
Research Site
Cedar Knolls, New Jersey, United States
Research Site
Passaic, New Jersey, United States
Research Site
Sicklerville, New Jersey, United States
Research Site
Great Neck, New York, United States
Research Site
Great Neck, New York, United States
Research Site
Johnson City, New York, United States
Research Site
Kingston, New York, United States
Research Site
Mineola, New York, United States
Research Site
New York, New York, United States
Research Site
Burlington, North Carolina, United States
Research Site
Charlotte, North Carolina, United States
Research Site
Elkin, North Carolina, United States
Research Site
Fayetteville, North Carolina, United States
Research Site
Greensboro, North Carolina, United States
Research Site
Greensboro, North Carolina, United States
Research Site
New Bern, North Carolina, United States
Research Site
Pinehurst, North Carolina, United States
Research Site
Raleigh, North Carolina, United States
Research Site
Wilmington, North Carolina, United States
Research Site
Wilmington, North Carolina, United States
Research Site
Winston-Salem, North Carolina, United States
Research Site
Bismarck, North Dakota, United States
Research Site
Fargo, North Dakota, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Columbus, Ohio, United States
Research Site
Mogadore, Ohio, United States
Research Site
Sylvania, Ohio, United States
Research Site
Zanesville, Ohio, United States
Research Site
Norman, Oklahoma, United States
Research Site
Oklahoma City, Oklahoma, United States
Research Site
Downington, Pennsylvania, United States
Research Site
Lancaster, Pennsylvania, United States
Research Site
Pittsburgh, Pennsylvania, United States
Research Site
Greer, South Carolina, United States
Research Site
Simpsonville, South Carolina, United States
Research Site
Chattanooga, Tennessee, United States
Research Site
Chattanooga, Tennessee, United States
Research Site
Germantown, Tennessee, United States
Research Site
Jackson, Tennessee, United States
Research Site
Kingsport, Tennessee, United States
Research Site
Knoxville, Tennessee, United States
Research Site
Memphis, Tennessee, United States
Research Site
Nashville, Tennessee, United States
Research Site
Austin, Texas, United States
Research Site
Corsicana, Texas, United States
Research Site
Dallas, Texas, United States
Research Site
Dallas, Texas, United States
Research Site
Fort Worth, Texas, United States
Research Site
Houston, Texas, United States
Research Site
Murray, Utah, United States
Research Site
Chesapeake, Virginia, United States
Research Site
Richmond, Virginia, United States
Research Site
Suffolk, Virginia, United States
Research Site
Virginia Beach, Virginia, United States
Research Site
Bellevue, Washington, United States
Research Site
Spokane, Washington, United States
Research Site
Spokane, Washington, United States
Research Site
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ATL1251/052/CL
Identifier Type: -
Identifier Source: org_study_id